**Core Concept**
Severe immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by isolated thrombocytopenia (low platelet count) due to platelet destruction and impaired platelet production. The treatment of choice aims to rapidly increase platelet count to prevent bleeding complications.

**Why the Correct Answer is Right**
The treatment of choice for severe ITP is corticosteroids, specifically intravenous methylprednisolone. Corticosteroids work by suppressing the immune system, reducing platelet destruction, and promoting platelet production. They act by inhibiting the expression of FcγRIIIa on macrophages and dendritic cells, thus reducing the clearance of opsonized platelets. Corticosteroids also decrease the production of autoantibodies against platelets.

**Why Each Wrong Option is Incorrect**
**Option A:** Splenectomy, while an effective treatment for ITP, is not the treatment of choice for severe ITP. It is typically reserved for patients who do not respond to first-line treatments.
**Option B:** Intravenous immunoglobulin (IVIG) is an effective treatment for acute ITP but is not the first-line treatment for severe ITP. It works by saturating the Fc receptors on macrophages and dendritic cells, reducing platelet destruction.
**Option C:** Platelet transfusions are not recommended in severe ITP as they can lead to alloimmunization and worsen the disease.

**Clinical Pearl / High-Yield Fact**
Corticosteroids, such as methylprednisolone, should be administered promptly in severe ITP to prevent bleeding complications and improve patient outcomes.

**Correct Answer:** A. Methylprednisolone.